Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia

Saved in:

Bibliographic Details
Published in:	Blood Vol. 122; no. 22; pp. 3694 - 3696
Main Authors:	Grisouard, Jean, Ojeda-Uribe, Mario, Looser, Renate, Hao-Shen, Hui, Lundberg, Pontus, Duek, Adrian, Jeandidier, Eric, Karow, Axel, Skoda, Radek C.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 21-11-2013
Subjects:	Clone Cells - pathology Dasatinib Female Genes, abl Humans Hydroxyurea - therapeutic use Janus Kinase 2 - genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Middle Aged Point Mutation Pyrimidines - therapeutic use Thiazoles - therapeutic use Thrombocythemia, Essential - complications Thrombocythemia, Essential - drug therapy Thrombocythemia, Essential - genetics Translocation, Genetic
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0006-4971 1528-0020
DOI:	10.1182/blood-2013-07-516385